Searching News Database: Restylane
HSMN NewsFeed - 14 Sep 2023
Galderma Launches Advanced New Serum with Alastin Skincare(R) - C-Radical Defense Antioxidant Serum
Galderma Launches Advanced New Serum with Alastin Skincare(R) - C-Radical Defense Antioxidant Serum
HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
HSMN NewsFeed - 24 Mar 2017
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer
HSMN NewsFeed - 11 Jan 2016
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada
HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
HSMN NewsFeed - 10 Feb 2009
Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
HSMN NewsFeed - 12 Sep 2006
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
Q-Med: Q-Med's First Product in the Field of Body Augmentations, MACROLANE, Approved in Europe
HSMN NewsFeed - 28 Jun 2006
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Additional items found! 20
Members Archive contains
20 additional stories matching:
Restylane
(Password required)
Restylane
(Password required)